(MedPage Today) — President Trump said he’s never taken GLP-1 receptor agonists but said he “probably should.” (New York Times)
People with diabetes and cancer lived longer and had lower hospitalization rates if they were taking GLP-1 drugs rather…
Source link : https://www.medpagetoday.com/endocrinology/generalendocrinology/119396
Author :
Publish date : 2026-01-13 17:50:00
Copyright for syndicated content belongs to the linked Source.
